DocSym
β
Searchsearch
Search
(H16.9) Keratitis, unspecified
More details coming soon
703 157 in individuals diagnosis keratitis, unspecified confirmed
Diagnosis keratitis, unspecified is diagnosed Men are 3.42% more likely than Women
363 599
Men receive the diagnosis keratitis, unspecified
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
339 558
Women receive the diagnosis keratitis, unspecified
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease keratitis, unspecified - Men aged 55-59 and Women aged 75-79
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features keratitis, unspecified
Absence or low individual and public risk
Keratitis, unspecified - what does this mean
Keratitis is an inflammation of the cornea, the clear, protective outer layer of the eye. it can be caused by a variety of factors, including infection, injury, allergies, dry eye, or contact lens overuse. symptoms may include redness, pain, light sensitivity, blurred vision, and discharge. treatment usually involves topical antibiotics, steroids, and antiviral medications.
What happens during the disease - keratitis, unspecified
Keratitis, unspecified is an inflammation of the cornea, the transparent outer layer of the eye. it is caused by a variety of factors, such as bacterial or viral infection, trauma, chemical exposure, or allergic reaction. symptoms include redness, pain, tearing, blurry vision, and sensitivity to light. it can cause long-term vision damage if left untreated. treatment typically involves antibiotics, antivirals, or other medications, depending on the cause of the inflammation.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Obtain a detailed history of the patient's symptoms and any recent eye trauma.
- Perform a comprehensive eye examination, including visual acuity, pupillary reaction, ocular motility and extraocular movements, and slit-lamp examination.
- Conduct a Schirmer tear test to measure tear production.
- Conduct a fluorescent dye staining test to detect any areas of corneal damage.
- Perform a corneal scraping to obtain a sample for further testing.
- Perform a culture test to detect any bacterial, viral, or fungal infection.
- Perform a biopsy of the corneal tissue to identify any underlying disease.
Treatment and Medical Assistance
Main goal of the treatment: To reduce inflammation and pain, and to prevent further damage to the cornea.
- Administering topical antibiotics to reduce risk of infection
- Prescribing topical corticosteroids to reduce inflammation
- Prescribing topical lubricants to reduce discomfort
- Prescribing topical antiviral medications to reduce viral infection
- Prescribing topical anti-inflammatory medications to reduce inflammation
- Prescribing topical cycloplegic medications to reduce pain and inflammation
- Prescribing oral antibiotics to reduce risk of infection
- Prescribing oral anti-inflammatory medications to reduce inflammation
- Prescribing oral antiviral medications to reduce viral infection
- Prescribing oral corticosteroids to reduce inflammation
- Prescribing oral cycloplegic medications to reduce pain and inflammation
- Prescribing topical immunomodulators to reduce inflammation
- Prescribing oral immunomodulators to reduce inflammation
- Prescribing topical anti-allergy medications to reduce inflammation
- Prescribing oral anti-allergy medications to reduce inflammation
- Prescribing topical antifungal medications to reduce risk of infection
- Prescribing oral antifungal medications to reduce risk of infection
- Prescribing topical antiviral medications to reduce viral infection
- Prescribing oral antiviral medications to reduce viral infection
- Prescribing topical antiseptic medications to reduce risk of infection
- Prescribing oral antiseptic medications to reduce risk of infection
- Prescribing topical nonsteroidal anti-inflammatory medications to reduce inflammation
- Prescribing oral nonsteroidal anti-inflammatory medications to reduce inflammation
- Prescribing topical antiglaucoma medications to reduce intraocular pressure
- Prescribing oral antiglaucoma medications to reduce intraocular pressure
- Prescribing topical anticholinergic medications to reduce inflammation
- Prescribing oral anticholinergic medications to reduce inflammation
- Prescribing topical antihistamine medications to reduce inflammation
- Prescribing oral antihistamine medications to reduce inflammation
- Prescribing topical decongestants to reduce inflammation
- Prescribing oral decongestants to reduce inflammation
- Prescribing topical mucolytics to reduce inflammation
- Prescribing oral mucolytics to reduce inflammation
- Prescribing topical anticholinesterase medications to reduce inflammation
- Prescribing oral anticholinesterase medications to reduce inflammation
- Prescribing topical antiglaucoma medications to reduce intraocular pressure
- Prescribing oral antiglaucoma medications to reduce intraocular pressure
- Performing corneal transplantation to reduce inflammation
- Performing laser surgery to reduce inflammation
- Performing cryotherapy to reduce inflammation
- Performing phototherapy to reduce inflammation
- Performing keratoplasty to reduce inflammation
15 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Keratitis, unspecified - Prevention
Keratitis, unspecified can be prevented by avoiding contact with people who have eye infections, wearing protective eyewear when engaging in activities that may cause eye injury, and regularly washing hands and avoiding touching the face or eyes. additionally, people should avoid using contact lenses for extended periods of time, and should practice good contact lens hygiene.